On Friday, Usana Health Sciences Inc (NYSE: USNA) opened higher 7.14% from the last session, before settling in for the closing price of $19.74. Price fluctuations for USNA have ranged from $18.69 to $41.83 over the past 52 weeks.
Annual sales at Consumer Defensive sector company slipped by -13.02% over the past five years. Company’s average yearly earnings per share was noted -33.20% at the time writing. With a float of $11.06 million, this company’s outstanding shares have now reached $18.27 million.
Let’s look at the performance matrix of the company that is accounted for 1700 employees.
Usana Health Sciences Inc (USNA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Packaged Foods industry is another important factor to consider. The insider ownership of Usana Health Sciences Inc is 39.46%, while institutional ownership is 61.06%. The most recent insider transaction that took place on Aug 28 ’25, was worth 165,408. Before that another transaction happened on Aug 07 ’25, when Company’s Director sold 1,058 for $29.10, making the entire transaction worth $30,789. This insider now owns 0 shares in total.
Usana Health Sciences Inc (USNA) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.64 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.49) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -33.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.14% during the next five years compared to -13.02% drop over the previous five years of trading.
Usana Health Sciences Inc (NYSE: USNA) Trading Performance Indicators
Check out the current performance indicators for Usana Health Sciences Inc (USNA). In the past quarter, the stock posted a quick ratio of 1.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42. Likewise, its price to free cash flow for the trailing twelve months is 7.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.89, a number that is poised to hit 0.40 in the next quarter and is forecasted to reach 2.10 in one year’s time.
Technical Analysis of Usana Health Sciences Inc (USNA)
Usana Health Sciences Inc (NYSE: USNA) saw its 5-day average volume 0.85 million, a positive change from its year-to-date volume of 0.19 million. As of the previous 9 days, the stock’s Stochastic %D was 54.34%.
During the past 100 days, Usana Health Sciences Inc’s (USNA) raw stochastic average was set at 12.51%, which indicates a significant decrease from 88.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.94 in the past 14 days, which was higher than the 0.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.78, while its 200-day Moving Average is $29.17. Nevertheless, the first resistance level for the watch stands at $21.77 in the near term. At $22.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.47. If the price goes on to break the first support level at $20.07, it is likely to go to the next support level at $18.98. The third support level lies at $18.37 if the price breaches the second support level.
Usana Health Sciences Inc (NYSE: USNA) Key Stats
There are currently 18,272K shares outstanding in the company with a market cap of 386.45 million. Presently, the company’s annual sales total 854,500 K according to its annual income of 42,030 K. Last quarter, the company’s sales amounted to 213,670 K and its income totaled -6,520 K.
